Siris Medical

Siris Medical, founded in 2013 by Colin Carpenter and Nicholas Mourlas, operates at the intersection of artificial intelligence and oncology to refine cancer treatment. The company was born from CEO Colin Carpenter's experiences during his training in the Department of Radiation Oncology at Stanford, where he identified significant variability in cancer care delivery. This led to a mission to aggregate treatment data from top healthcare centers and present it efficiently to clinicians, enabling better-informed decisions.

The firm provides an AI-driven decision support system for radiation therapy, targeting healthcare providers, practitioners, and payers. Its primary offering is the InsightRT software suite, a platform with FDA 510(k) clearance that analyzes extensive clinical data to assist in creating personalized radiation treatment plans. The software suite has two main components: InsightRT Clinical Decision Support (CDS) and InsightRT Prior Authorization (PA). The CDS platform, which includes the QuickMatch module, leverages a proprietary database of over 30,000 patient datasets and 10 million clinical images to match new patients with historical successful cases, helping clinicians determine optimal treatment strategies and reduce potential side effects. The PA module works to streamline the insurance authorization process, aiming to reduce delays in patient care by aligning provider treatment directives with payer guidelines from the start.

The business model centers on providing these software tools to clinical teams in both academic medical centers and community settings. By automating and improving the treatment planning process, the platform can reduce operational expenses, with studies showing it can save up to 70% of the time required for planning. Research published with the Dana-Farber Cancer Institute indicated the tool could lower the risk of major adverse cardiac events. Siris Medical was acquired by TurningPoint Healthcare Solutions in December 2022.

Keywords: radiation oncology, clinical decision support, artificial intelligence, cancer treatment, treatment planning, prior authorization, healthtech, medical software, oncology data analytics, radiotherapy AI, dosimetric outcomes, patient-specific treatment, care alignment, FDA 510(k) cleared, Colin Carpenter, oncology workflow, radiation therapy software, medical imaging AI, healthcare data mining, TurningPoint Healthcare Solutions